期刊文献+

肾血管性高血压103例临床分析 被引量:5

下载PDF
导出
摘要 目的分析肾血管性高血压(RVH)的发病原因、临床表现和辅助检查及诊断和治疗情况。方法回顾性对2000-01-2007-01期间诊断为RVH的患者103例的临床资料进行分析。结果多发性大动脉炎(TA)、肾动脉粥样硬化(AS)、肾纤维肌性营养不良(FMD)分别占RVH病因的39.8%、27.2%、17.5%。肾动脉造影是诊断RVH的金标准。TA腹部血管杂音检出多于AS和纤维肌性发育不良组。AS病变多位于肾动脉开口处或近端1/3,狭窄多为偏心性;TA病变多位于肾动脉开口处,且多为二支以上血管病变,多呈局限性病变;FMD病变位于肾动脉中远端,多呈典型串珠样改变。介入治疗组的疗效明显高于药物治疗组。结论RVH的病因中,仍以TA、AS和FMD多见,AS所占比例增加。介入治疗是RVH主要的治疗方法。
出处 《中华高血压杂志》 CAS CSCD 北大核心 2007年第10期859-860,共2页 Chinese Journal of Hypertension
  • 相关文献

参考文献7

  • 1[1]Safian RD.Atherosclerotic renal artery stenosis[J].Current Treat Options cardiovascular Med,2003,5:91-101.
  • 2[3]Fatica RA,Port FK,Young EW.Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States[J].Am J Kidney Dis,2001,37:1184-1190.
  • 3[4]Rundback JH,Sacks D,Kent KC,et al.Guidelines for the reporting of renal artery revascularization in clinical trials[J].Circulation,2002,106:1572-1585.
  • 4[5]Greco BA,Breyer JA.Atherosclerotic ischemic renal diease[J].Am J Kid Dis,1997,29:167-187.
  • 5[6]Harding MB,Smith LR,Himmjestein SI,et al.Renal artery stenosis:prevalence and associated risk factors in patients undergoing routine cardiac cathcterization[J].J AM Soc Nephrol,1992,2:1608.
  • 6[7]Sharr BK,Sagar S,Chugh KS,et al.Spectrum of renovascular hypertension in the young in north India a hospital based study on occurence and clinical features[J].Angiogrophylogy,1985,36:370.
  • 7蒋雄京,明广华,吴海英,王蕾礼,王静,郑德裕,刘国仗,刘力生.支架重建血运治疗肾动脉狭窄初步结果[J].中华内科杂志,2002,41(2):82-85. 被引量:11

二级参考文献9

  • 1Schreiber MJ, Pohi MA, Novich AC. The natural history of atherosclerotic and fibrous renal artery disease. Urol Clin North Am,1984,11:383-392.
  • 2Caps MT, Perissinotto C, Zierler RE, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation, 1998, 98: 2866-2872.
  • 3Van Jaarsveld BC, Krijnen P, Pieterman H, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N Engl J Med,2000,342:1007-1014.
  • 4Plouin PF, Chatellier G, Darne B, et al. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: a randomized trial. Essai Multiontrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension, 1998,31: 823-829.
  • 5Webster J, Marshall F, Abdalla M, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scattish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens, 1998,12: 329-335.
  • 6Hennequin LM, Joffre FG, Rousseau HP, et al. Renal artery stent placement: long-term results with the Wallstent endoprosthesis. Radiology, 1994, 191: 713-719.
  • 7van de Ven PJ, Beutler JJ, Kaatee R, et al. Transluminal vascular stent for ostial atherosclerotic renal artery stenosis. Lancet, 1995, 346 : 672-673.
  • 8Dong ZJ, Li SH, Lu XC. Percutaneous transluminal angioplasty for renovascular hypertension in arteritis: experience in China. Radiology, 1987, 162: 477-479.
  • 9Sos TA, Picketing TG, Sniderman K, et al. Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med, 1983, 309: 274-279.

共引文献10

同被引文献73

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部